These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 8011517)

  • 21. An in silico and in vitro approach to elucidate the impact of residues flanking the cleavage scissile bonds of FVIII.
    Pezeshkpoor B; Schreck U; Biswas A; Driesen J; Berkemeier AC; Pavlova A; Müller J; Oldenburg J
    PLoS One; 2017; 12(7):e0180456. PubMed ID: 28683085
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The diversity of the immune response to the A2 domain of human factor VIII.
    Markovitz RC; Healey JF; Parker ET; Meeks SL; Lollar P
    Blood; 2013 Apr; 121(14):2785-95. PubMed ID: 23349389
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Diagnostic accuracy study of a factor VIII ELISA for detection of factor VIII antibodies in congenital and acquired haemophilia A.
    Batty P; Moore GW; Platton S; Maloney JC; Palmer B; Bowles L; Pasi KJ; Rangarajan S; Hart DP
    Thromb Haemost; 2015 Oct; 114(4):804-11. PubMed ID: 26063073
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A monoclonal antibody (NMC-VIII/10) to factor VIII light chain recognizing Glu1675-Glu1684 inhibits factor VIII binding to endogenous von Willebrand factor in human umbilical vein endothelial cells.
    Shima M; Yoshioka A; Nakajima M; Nakai H; Fukui H
    Br J Haematol; 1992 Aug; 81(4):533-8. PubMed ID: 1390241
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Detection and characterisation of two missense mutations at a cleavage site in the factor VIII light chain.
    Schwaab R; Ludwig M; Kochhan L; Oldenburg J; McVey JH; Egli H; Brackmann HH; Olek K
    Thromb Res; 1991 Feb; 61(3):225-34. PubMed ID: 1851341
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Relationships between factor VIII:Ag and factor VIII in recombinant and plasma-derived factor VIII concentrates.
    Lin Y; Yang X; Chevrier MC; Craven S; Barrowcliffe TW; Lemieux R; Ofosu FA
    Haemophilia; 2004 Sep; 10(5):459-69. PubMed ID: 15357771
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Measurement of factor VIII procoagulant antigen in normal subjects and in hemophilia A patients by an immunoradiometric assay and by an enzyme-linked immunosorbent assay.
    Hellstern P; Miyashita C; Köhler M; von Blohn G; Kiehl R; Biro G; Schwerdt H; Wenzel E
    Haemostasis; 1987; 17(4):173-81. PubMed ID: 3114101
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Localization of a factor VIII-inhibiting antibody epitope to a region between residues 338 and 362 of factor VIII heavy chain.
    Ware J; Toomey JR; Stafford DW
    Proc Natl Acad Sci U S A; 1988 May; 85(9):3165-9. PubMed ID: 2452445
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Characterization of human hybridoma clones isolated from hemophilia patients with specificity for different domains of coagulating factor VIII.
    Gharagozlou S; Ghods R; Bahrami ZS; Roohi A; Jeddi-Tehrani M; Conti-Fine BM; Sharifian RA; Rabbani H; Shokri F
    Hum Antibodies; 2003; 12(3):67-76. PubMed ID: 14646035
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Epitope specificity of anti-factor VIII antibodies from inhibitor positive acquired and congenital haemophilia A patients using synthetic peptides spanning A and C domains.
    Gharagozlou S; Sharifian RA; Khoshnoodi J; Karimi K; Milani M; Okita DK; Shokri F; Conti-Fine BM
    Thromb Haemost; 2009 May; 101(5):834-9. PubMed ID: 19404535
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Factor VIII C2 domain contains the thrombin-binding site responsible for thrombin-catalyzed cleavage at Arg1689.
    Nogami K; Shima M; Hosokawa K; Nagata M; Koide T; Saenko EL; Tanaka I; Shibata M; Yoshioka A
    J Biol Chem; 2000 Aug; 275(33):25774-80. PubMed ID: 10831589
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Factor VIII: Long-established role in haemophilia A and emerging evidence beyond haemostasis.
    Samuelson Bannow B; Recht M; Négrier C; Hermans C; Berntorp E; Eichler H; Mancuso ME; Klamroth R; O'Hara J; Santagostino E; Matsushita T; Kessler C
    Blood Rev; 2019 May; 35():43-50. PubMed ID: 30922616
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Haemophilia A mutations in patients with non-severe phenotype associated with a discrepancy between one-stage and chromogenic factor VIII activity assays.
    Pavlova A; Delev D; Pezeshkpoor B; Müller J; Oldenburg J
    Thromb Haemost; 2014 May; 111(5):851-61. PubMed ID: 24452774
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Differential proteolytic activation of factor VIII-von Willebrand factor complex by thrombin.
    Hill-Eubanks DC; Parker CG; Lollar P
    Proc Natl Acad Sci U S A; 1989 Sep; 86(17):6508-12. PubMed ID: 2505252
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The mild phenotype in severe hemophilia A with Arg1781His mutation is associated with enhanced binding affinity of factor VIII for factor X.
    Yada K; Nogami K; Wakabayashi H; Fay PJ; Shima M
    Thromb Haemost; 2013 Jun; 109(6):1007-15. PubMed ID: 23467620
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Thrombin generation as objective parameter of treatment response in patients with severe haemophilia A and high-titre inhibitors.
    Luna-Záizar H; Beltrán-Miranda CP; Esparza-Flores MA; Soto-Padilla J; Bergés-García A; Rodríguez-Zepeda MD; Pompa-Garza MT; Jaloma-Cruz AR
    Haemophilia; 2014 Jan; 20(1):e7-14. PubMed ID: 24354488
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Amino acid residues 721-729 are required for full factor VIII activity.
    Kjalke M; Heding A; Talbo G; Persson E; Thomsen J; Ezban M
    Eur J Biochem; 1995 Dec; 234(3):773-9. PubMed ID: 8575434
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The role of cleavage of the light chain at positions Arg1689 or Arg1721 in subunit interaction and activation of human blood coagulation factor VIII.
    Donath MS; Lenting PJ; van Mourik JA; Mertens K
    J Biol Chem; 1995 Feb; 270(8):3648-55. PubMed ID: 7876103
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Characterization of des-(741-1668)-factor VIII, a single-chain factor VIII variant with a fusion site susceptible to proteolysis by thrombin and factor Xa.
    Donath MJ; de Laaf RT; Biessels PT; Lenting PJ; van de Loo JW; van Mourik JA; Voorberg J; Mertens K
    Biochem J; 1995 Nov; 312 ( Pt 1)(Pt 1):49-55. PubMed ID: 7492334
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Factor VIII gene analysis in Japanese CRM-positive and CRM-reduced haemophilia A patients by single-strand conformation polymorphism.
    Morichika S; Shima M; Kamisue S; Tanaka I; Imanaka Y; Suzuki H; Shibata H; Pemberton S; Gale K; McVey J; Tuddenham EG; Yoshioka A
    Br J Haematol; 1997 Sep; 98(4):901-6. PubMed ID: 9326186
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.